Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT)
• Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 G...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Brecht, Susan [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
12 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells - Han, Xiaobing ELSEVIER, 2021, journal of the European Society for Therapeutic Radiology and Oncology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:134 ; year:2019 ; pages:166-177 ; extent:12 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.radonc.2019.02.003 |
|---|
| Katalog-ID: |
ELV046478620 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV046478620 | ||
| 003 | DE-627 | ||
| 005 | 20230624123353.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.radonc.2019.02.003 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000782.pica |
| 035 | |a (DE-627)ELV046478620 | ||
| 035 | |a (ELSEVIER)S0167-8140(19)30069-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Brecht, Susan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) |
| 264 | 1 | |c 2019 | |
| 300 | |a 12 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. | ||
| 650 | 7 | |a RION |2 Elsevier | |
| 650 | 7 | |a IMRT |2 Elsevier | |
| 650 | 7 | |a OS |2 Elsevier | |
| 650 | 7 | |a D<ce:inf loc="post">max</ce:inf> |2 Elsevier | |
| 650 | 7 | |a MRI |2 Elsevier | |
| 650 | 7 | |a DM |2 Elsevier | |
| 650 | 7 | |a VFAR |2 Elsevier | |
| 650 | 7 | |a 3DCRT |2 Elsevier | |
| 650 | 7 | |a AVP |2 Elsevier | |
| 650 | 7 | |a CBCT |2 Elsevier | |
| 650 | 7 | |a EQD-2 |2 Elsevier | |
| 700 | 1 | |a Boda-Heggemann, Judit |4 oth | |
| 700 | 1 | |a Budjan, Johannes |4 oth | |
| 700 | 1 | |a Siebenlist, Kerstin |4 oth | |
| 700 | 1 | |a Stieler, Florian |4 oth | |
| 700 | 1 | |a Steil, Volker |4 oth | |
| 700 | 1 | |a Wenz, Frederik |4 oth | |
| 700 | 1 | |a Lohr, Frank |4 oth | |
| 700 | 1 | |a Buergy, Daniel |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Han, Xiaobing ELSEVIER |t Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |d 2021 |d journal of the European Society for Therapeutic Radiology and Oncology |g Amsterdam [u.a.] |w (DE-627)ELV00004122X |
| 773 | 1 | 8 | |g volume:134 |g year:2019 |g pages:166-177 |g extent:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2019.02.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 134 |j 2019 |h 166-177 |g 12 | ||
| author_variant |
s b sb |
|---|---|
| matchkey_str |
brechtsusanbodaheggemannjuditbudjanjohan:2019----:aitoidcdpinuoahatrtroatcniaeuddnestmd |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.1016/j.radonc.2019.02.003 doi GBV00000000000782.pica (DE-627)ELV046478620 (ELSEVIER)S0167-8140(19)30069-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Brecht, Susan verfasserin aut Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 Elsevier Boda-Heggemann, Judit oth Budjan, Johannes oth Siebenlist, Kerstin oth Stieler, Florian oth Steil, Volker oth Wenz, Frederik oth Lohr, Frank oth Buergy, Daniel oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:134 year:2019 pages:166-177 extent:12 https://doi.org/10.1016/j.radonc.2019.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 134 2019 166-177 12 |
| spelling |
10.1016/j.radonc.2019.02.003 doi GBV00000000000782.pica (DE-627)ELV046478620 (ELSEVIER)S0167-8140(19)30069-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Brecht, Susan verfasserin aut Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 Elsevier Boda-Heggemann, Judit oth Budjan, Johannes oth Siebenlist, Kerstin oth Stieler, Florian oth Steil, Volker oth Wenz, Frederik oth Lohr, Frank oth Buergy, Daniel oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:134 year:2019 pages:166-177 extent:12 https://doi.org/10.1016/j.radonc.2019.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 134 2019 166-177 12 |
| allfields_unstemmed |
10.1016/j.radonc.2019.02.003 doi GBV00000000000782.pica (DE-627)ELV046478620 (ELSEVIER)S0167-8140(19)30069-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Brecht, Susan verfasserin aut Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 Elsevier Boda-Heggemann, Judit oth Budjan, Johannes oth Siebenlist, Kerstin oth Stieler, Florian oth Steil, Volker oth Wenz, Frederik oth Lohr, Frank oth Buergy, Daniel oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:134 year:2019 pages:166-177 extent:12 https://doi.org/10.1016/j.radonc.2019.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 134 2019 166-177 12 |
| allfieldsGer |
10.1016/j.radonc.2019.02.003 doi GBV00000000000782.pica (DE-627)ELV046478620 (ELSEVIER)S0167-8140(19)30069-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Brecht, Susan verfasserin aut Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 Elsevier Boda-Heggemann, Judit oth Budjan, Johannes oth Siebenlist, Kerstin oth Stieler, Florian oth Steil, Volker oth Wenz, Frederik oth Lohr, Frank oth Buergy, Daniel oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:134 year:2019 pages:166-177 extent:12 https://doi.org/10.1016/j.radonc.2019.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 134 2019 166-177 12 |
| allfieldsSound |
10.1016/j.radonc.2019.02.003 doi GBV00000000000782.pica (DE-627)ELV046478620 (ELSEVIER)S0167-8140(19)30069-6 DE-627 ger DE-627 rakwb eng 570 540 VZ Brecht, Susan verfasserin aut Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) 2019 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 Elsevier Boda-Heggemann, Judit oth Budjan, Johannes oth Siebenlist, Kerstin oth Stieler, Florian oth Steil, Volker oth Wenz, Frederik oth Lohr, Frank oth Buergy, Daniel oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:134 year:2019 pages:166-177 extent:12 https://doi.org/10.1016/j.radonc.2019.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 134 2019 166-177 12 |
| language |
English |
| source |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:134 year:2019 pages:166-177 extent:12 |
| sourceStr |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:134 year:2019 pages:166-177 extent:12 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
RION IMRT OS D<ce:inf loc="post">max</ce:inf> MRI DM VFAR 3DCRT AVP CBCT EQD-2 |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| authorswithroles_txt_mv |
Brecht, Susan @@aut@@ Boda-Heggemann, Judit @@oth@@ Budjan, Johannes @@oth@@ Siebenlist, Kerstin @@oth@@ Stieler, Florian @@oth@@ Steil, Volker @@oth@@ Wenz, Frederik @@oth@@ Lohr, Frank @@oth@@ Buergy, Daniel @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00004122X |
| dewey-sort |
3570 |
| id |
ELV046478620 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046478620</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624123353.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2019.02.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000782.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046478620</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(19)30069-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brecht, Susan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RION</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IMRT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">D<ce:inf loc="post">max</ce:inf></subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VFAR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">3DCRT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AVP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CBCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EQD-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boda-Heggemann, Judit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Budjan, Johannes</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Siebenlist, Kerstin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stieler, Florian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steil, Volker</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wenz, Frederik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lohr, Frank</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buergy, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:134</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:166-177</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2019.02.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">134</subfield><subfield code="j">2019</subfield><subfield code="h">166-177</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| author |
Brecht, Susan |
| spellingShingle |
Brecht, Susan ddc 570 Elsevier RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) |
| authorStr |
Brecht, Susan |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00004122X |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 540 VZ Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 Elsevier |
| topic |
ddc 570 Elsevier RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 |
| topic_unstemmed |
ddc 570 Elsevier RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 |
| topic_browse |
ddc 570 Elsevier RION Elsevier IMRT Elsevier OS Elsevier D<ce:inf loc="post">max</ce:inf> Elsevier MRI Elsevier DM Elsevier VFAR Elsevier 3DCRT Elsevier AVP Elsevier CBCT Elsevier EQD-2 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j b h jbh j b jb k s ks f s fs v s vs f w fw f l fl d b db |
| hierarchy_parent_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| hierarchy_parent_id |
ELV00004122X |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00004122X |
| title |
Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) |
| ctrlnum |
(DE-627)ELV046478620 (ELSEVIER)S0167-8140(19)30069-6 |
| title_full |
Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) |
| author_sort |
Brecht, Susan |
| journal |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| journalStr |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
166 |
| author_browse |
Brecht, Susan |
| container_volume |
134 |
| physical |
12 |
| class |
570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Brecht, Susan |
| doi_str_mv |
10.1016/j.radonc.2019.02.003 |
| dewey-full |
570 540 |
| title_sort |
radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (imrt) |
| title_auth |
Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) |
| abstract |
• Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. |
| abstractGer |
• Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. |
| abstract_unstemmed |
• Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT) |
| url |
https://doi.org/10.1016/j.radonc.2019.02.003 |
| remote_bool |
true |
| author2 |
Boda-Heggemann, Judit Budjan, Johannes Siebenlist, Kerstin Stieler, Florian Steil, Volker Wenz, Frederik Lohr, Frank Buergy, Daniel |
| author2Str |
Boda-Heggemann, Judit Budjan, Johannes Siebenlist, Kerstin Stieler, Florian Steil, Volker Wenz, Frederik Lohr, Frank Buergy, Daniel |
| ppnlink |
ELV00004122X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.radonc.2019.02.003 |
| up_date |
2024-07-06T20:20:26.091Z |
| _version_ |
1803862384145596416 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV046478620</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624123353.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2019.02.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000782.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV046478620</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(19)30069-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brecht, Susan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Severe RION is rare after normofractionated stereotactic IGRT/IMRT (incidence 1.2%) • The RION risk did not increase at doses of ≤55 Gy, 55–58 Gy or 13 patients with ≥58 Gy. • The risk of tumor-associated blindness or death was higher in all dose strata. • In aggressive tumors, point doses of 58 Gy to the optical pathway may be acceptable.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RION</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IMRT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">D<ce:inf loc="post">max</ce:inf></subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DM</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VFAR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">3DCRT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AVP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CBCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EQD-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boda-Heggemann, Judit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Budjan, Johannes</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Siebenlist, Kerstin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stieler, Florian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steil, Volker</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wenz, Frederik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lohr, Frank</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buergy, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:134</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:166-177</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2019.02.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">134</subfield><subfield code="j">2019</subfield><subfield code="h">166-177</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| score |
7.4020147 |